Gusto Global, LLC

Class 042: Research and development of therapeutics, consumer products, diagnostic and prognostic tools and methods consisting of designed ecologies of combinations of microorganisms, or individually selected microorganisms for the treatment and prevention of immune diseases, including food allergy desensitization, asthma, and inflammation, infections, including sepsis and surgery-associated infections, and infections with Clostridium difficile, oncology, including colon cancer and carcinomas, and neurological conditions, such as Alzheimer's disease, autism spectrum disorder, dementia, Parkinson's disease, and pre- and post-natal depression

Scientific research services, namely, DNA sequencing, bioinformatics analysis, interpretation of biological DNA data, and microbiome analysis; Scientific research services, namely, DNA sequencing, bioinformatics analysis, interpretation of biological DNA data, and microbiome analysis for patient diagnosis and treatment; Scientific research services, namely, DNA sequencing, bioinformatics analysis, interpretation of biological DNA data, and microbiome analysis for medical, therapeutic and nutritional use; Scientific investigations for medical purposes; Scientific research | DNA sequencing, bioinformatics analysis, and interpretation of biological DNA data, and microbiome analysis for medical purposes; DNA sequencing, bioinformatics analysis, interpretation of biological DNA data, and microbiome analysis for patient diagnosis and treatment; DNA sequencing, bioinformatics analysis, and interpretation of biological DNA data, and microbiome analysis for medical, therapeutic and nutritional use; Medical services; Providing medical information

"MINIMAL MICROBIOME THERAPY"

"GLOBAL" AND "THE MICROBIOME ECOLOGY COMPANY"

"GLOBAL"